Home Detailed Analysis

Detailed Analysis

Latest

Detailed Analysis

Eyegate Pharmaceuticals (EYEG) Stock: Definitely Worth Considering

Joshua Rodriguez - April 23, 2018

Detailed Analysis

Jaguar Health (JAGX) Stock: Digging Deeper Into This Potential Opportunity

Detailed Analysis

22nd Century Group (XXII) Stock: Should You Consider This Stock?

Detailed Analysis

MannKind Corporation (MNKD) Stock: Is Now The Time To Get Involved?

Detailed Analysis

Idera Pharmaceuticals (IDRA) Stock: Diamond In The Rough Or Lump Of Coal?

Detailed Analysis

Northern Dynasty Minerals (NAK) Stock: Are You Paying Attention Yet?

Joshua Rodriguez - March 6, 2018

Detailed Analysis

Helios And Matheson Analytics: Something’s Gotta Give!

Joshua Rodriguez - February 28, 2018

Detailed Analysis

Exact Sciences (EXAS) Stock: Cologuard Is Becoming More And More...

Joshua Rodriguez - February 28, 2018

Detailed Analysis

Novavax (NVAX) Stock: Could Be A Massive Win For All Involved!

Joshua Rodriguez - February 28, 2018

Cellectar Biosciences CLRB Stock News

Biotech Stocks

Cellectar Biosciences (CLRB) Stock: A Compelling Opportunity In The Making

Joshua Rodriguez - April 18, 2019

The oncology space is one that is undergoing a rapid evolution. With nearly 600,000 deaths per year, cancer is the second leading...

Veritas Farms VFRM Stock News

Veritas Farms (VFRM) Stock: A Dip Worth Buying!

April 18, 2019

Canopy Growth Corp CGC Stock News

Canopy Growth (CGC) Stock: Announces US Cannabis Acquisition

April 18, 2019

Reviews

TradeMiner Review

Reviews

TradeMiner Review: Is It Worth Your While?

Joshua Rodriguez - February 20, 2019

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...

TradeIdeas Review

Trade Ideas Review: A Deep Dive Into What They Have To...

February 20, 2019

TradeSpoon Review

Tradespoon Review: Is The Service Worth Your Money?

February 20, 2019

TradeKing Review

TradeKing Review 2015 – Read This Before Signing Up

February 20, 2019

Disclaimer- CNA Finance is NOT an Investment Advisor. Our goal is to bring both news and under discovered stocks to the attention of investors to assist in making smart decisions in the market. CNA Finance is a for profit company. That profit is generated through three (3) different types of relationships. First and foremost, we work with pay per click and CPM advertisers on banners. We also have affiliate relationships with various companies where we earn a portion of the sales revenue that we refer. Finally, we may have relationships with some of the companies or IR firms that represent companies mentioned within our works in which we are compensated in cash and or stock for consulting, investor relations, and Press Release services (click here for details). Therefore, while we do everything in our power to provide true, well-researched, and well-thought out opinions, in some instances, a potential conflict of interest may exist. CNA Finance encourages all investors to seek professional advice before making any investment decision.